Phama Company Shares Rise Ahead of FDA Review
02 November 2021 - 2:09AM
AllPennyStocks.com
After a surprising rejection in August, two pharma companies are
working toward approval ahead of their Type A meeting with the FDA
for a drug with significant potential
Medexus...
To read the full story on AllPennyStocks.com, click
here.
Medexus Pharmaceuticals (TSX:MDP)
Historical Stock Chart
From May 2024 to Jun 2024
Medexus Pharmaceuticals (TSX:MDP)
Historical Stock Chart
From Jun 2023 to Jun 2024